Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Unicycive Therapeutics, Inc. (UNCY), Hims & Hers Health, Inc. (HIMS), and Beta Bionics, Inc. (BBNX) Announced by Holzer & Holzer, LLC

Holzer & Holzer, LLC issued a promotional notice reminding investors of lead plaintiff deadlines in shareholder class actions against Unicycive Therapeutics, Hims & Hers, and Beta Bionics. The lawsuit against Beta Bionics (BBNX) alleges misleading statements between July 30, 2025 and February 24, 2026 regarding safety of the iLet Bionic Pancreas insulin pump, with a lead plaintiff deadline of November 3, 2026.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.